EME Medical
EME Medical › Drug encyclopedia

💊 Buprenorphine (Buprenorphine)

💊 Partial opioid agonist

Buprenorphine sublingual tablets are indicated for the treatment of opioid dependence and are preferred for induction. They should be used as part of a complete treatment plan that includes counseling and psychosocial support.

🏷️ Brands: Buprenorphine💉 Sublingual📋 Prescription only
In Arabic: بوبرينورفين
Chemical structure of Buprenorphine
ⓘ

🏷️ Brand names & manufacturers

Brixadi — Braeburn Inc.Brixadi🏭 Braeburn Inc.DailyMed
Sublocade — Indivior Inc.Sublocade🏭 Indivior Inc.DailyMed
Butrans — Knoa Pharma LLCButrans🏭 Knoa Pharma LLCDailyMed
Buprenorphine Transdermal System — Alvogen Inc.Buprenorphine Transdermal System🏭 Alvogen Inc.DailyMed
Buprenorphine — Actavis Pharma, Inc.Buprenorphine🏭 Actavis Pharma, Inc.DailyMed
Buprenorphine — AvPAKBuprenorphine🏭 AvPAKDailyMed
💊
Buprenorphine🏭 INGENUS PHARMACEUTICALS, LLC
Packages shown are US-market (DailyMed). Brands available in Palestine are in the price section below.

✅ What it is used for

🧪 Active ingredient

Buprenorphine: a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor.

🌿 Benefits

📝 How to use

💊 Dosage forms

⚠️ Common side effects

  • Oral hypoesthesia
  • Glossodynia
  • Oral mucosal erythema
  • Headache
  • Nausea
  • Vomiting
  • Hyperhidrosis
  • Constipation
  • Signs and symptoms of withdrawal
  • Insomnia
  • Pain
  • Peripheral edema

🚨 Serious — seek medical help

  • Addiction, abuse, and misuse
  • Respiratory and CNS depression
  • Neonatal opioid withdrawal syndrome
  • Adrenal insufficiency
  • Opioid withdrawal
  • Hepatitis, hepatic events
  • Hypersensitivity reactions
  • Orthostatic hypotension
  • Elevation of cerebrospinal fluid pressure
  • Elevation of intracholedochal pressure

⛔ Do not use if

❗ Warnings & precautions

🔄 Drug interactions

🤰 Pregnancy

Data on use of buprenorphine in pregnancy are limited; however, these data do not indicate an increased risk of major malformations specifically due to buprenorphine exposure. There are limited data from randomized clinical trials in women maintained on buprenorphine that were not designed appropriately to assess the risk of major malformations. Observational studies have reported congenital malformations among buprenorphine-exposed pregnancies but were also not designed appropriately. Reproductive and developmental studies in rats and rabbits identified adverse events at clinically relevant and higher doses. Based on animal data, advise pregnant women of the potential risk to a fetus.

🍼 Breastfeeding

Buprenorphine passes into mother's milk. Based on two studies in 13 lactating women, buprenorphine and its metabolite norbuprenorphine were present in low levels in human milk and available data have not shown adverse reactions in breastfed infants. Consider the developmental and health benefits of breastfeeding along with the mother's clinical need and any potential adverse effects on the breastfed child. Advise breastfeeding women to monitor the infant for increased drowsiness and breathing difficulties.

🧒 Children

The safety and effectiveness of buprenorphine sublingual tablets have not been established in pediatric patients.

👴 Older adults

Clinical studies did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently than younger subjects. Due to possible decreased hepatic, renal, or cardiac function and concomitant disease or other drug therapy, prescribe cautiously in individuals 65 years of age or older and monitor for signs and symptoms of toxicity or overdose.

🌡️ Storage

Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F). Dispense in a tight, light-resistant container. Store securely and dispose of properly.

🆘 Overdose

Manifestations of acute overdose include pinpoint pupils, sedation, hypotension, hypoglycemia, respiratory depression, and death. Monitor respiratory and cardiac status carefully; when depressed, re-establish adequate respiratory exchange through a patent airway and assisted or controlled ventilation. Oxygen, IV fluids, vasopressors, and other supportive measures should be employed as indicated. An opioid overdose reversal agent may be of value; higher than normal doses and repeated administration may be necessary. Consider the long duration of action of buprenorphine when determining the length of treatment and medical surveillance.

💰 Price & brands in your area

Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.

📍 Find the nearest pharmacy

Your location is used only in your browser to show nearby pharmacies — we don't store it.

Open in Google Maps

👨‍⚕️ For healthcare professionals

Mechanism of action

Buprenorphine is a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor.

Labeled dosing

Administer sublingually as a single daily dose. Induction should be undertaken when objective and clear signs of withdrawal are evident. Buprenorphine and naloxone sublingual film or tablet is generally initiated after two days of buprenorphine sublingual tablets titration. Administer tablets whole; do not cut, chew, or swallow. When discontinuing treatment, gradually taper.

🎓 Key points for students

🩺 Run a clinic or medical center?

EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.

Try EME free   How we protect your data

❓ FAQ

How do I take buprenorphine sublingual tablets?

Administer sublingually as a single daily dose. The tablet must be taken whole; do not cut, chew, or swallow it. The dose is set by the doctor or pharmacist.

Can buprenorphine cause withdrawal?

Yes, an opioid withdrawal syndrome is likely with parenteral misuse or with sublingual administration before the agonist effects of other opioids have subsided; induction should be undertaken when objective and clear signs of withdrawal are evident.

What are the most important drug interactions?

Benzodiazepines or other CNS depressants, including alcohol, increase the risk of respiratory depression, profound sedation, coma, and death. CYP3A4 inhibitors can increase buprenorphine plasma concentrations.

Can it be used during pregnancy or breastfeeding?

Pregnancy data are limited but do not indicate an increased risk of major malformations specifically due to buprenorphine; advise pregnant women of the potential risk to a fetus. Buprenorphine passes into mother's milk at low levels; advise breastfeeding women to monitor the infant for increased drowsiness and breathing difficulties.

What should I do in case of overdose?

Manifestations include pinpoint pupils, sedation, hypotension, hypoglycemia, and respiratory depression. Seek emergency medical help; treatment includes monitoring respiratory and cardiac status and re-establishing adequate ventilation, and an opioid overdose reversal agent may be of value.

⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-05), simplified. Updated: 2026-11-16.